Kontakt
Investor Relations
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q121/app/uploads/5c956995-f688-43b6-9513-ee567d844610.jpeg?width=1240&crop=%28179%2C112%2C958%2C698%29&quality=60)
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q121/app/uploads/0b6a3f26-ebd0-4e7c-8224-f0da163149ad.jpeg?width=1240&crop=%28129%2C133%2C1068%2C839%29&quality=60)
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q121/app/uploads/9cd1b639-0cf4-41b9-b531-fc44eb40db97.jpeg?width=1240&crop=%280%2C269%2C1378%2C1305%29&quality=60)
Media Relations
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q121/app/uploads/983f09d2-4f5d-4d65-b69d-88e866526ded.jpeg?width=1240&crop=%280%2C94%2C919%2C785%29&quality=60)
BB Biotech AG
Schwertstrasse 6
CH-8200 Schaffhausen
E-Mail info@bbbiotech.com
www.bbbiotech.com
Bellevue Asset Management AG
Seestrasse 16/Postfach
CH-8700 Küsnacht
Telefon +41 44 267 67 00
E-Mail info@bellevue.ch
www.bellevue.ch
BB biotech Newsletter
Möchten Sie zukünftig regelmässig über BB Biotech informiert werden? Melden Sie sich hier für unseren Newsletter an.
Zur ANmeldung